IV Prostanoids in Systemic Sclerosis-Associated PAH IV Prostanoids in Systemic Sclerosis-Associated PAH

What role could IV prostanoid therapy have in the treatment of systemic sclerosis-associated pulmonary arterial hypertension?Rheumatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news